Prosecution Insights
Last updated: October 25, 2026

Squire Pb (Sfr Office)

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

165 pending office actions • 83 clients • 156 examiners • 114 art units • 11 of 165 (7%) have an AI response strategy ready

Quality Metrics (n=12386 apps, methodology: how we score firms)

83.1%
Allowance Rate
n=12386
+0.45σ
Allowance Rate (norm)
n=12386
3.8
OAs to Allowance
n=8272
+0.16σ
OAs to Allow (norm)
n=8272
1104 days
Time to Allowance
n=8272
+11.3pp
Interview Lift
n=12386
31.2%
RCE Rate
n=12386
2.5%
Appeal Rate
n=12386

Rejection Performance (% of received rejections ultimately overcome)

82.0%
§101 Overcome
n=1418
79.8%
§102 Overcome
n=3618
80.7%
§103 Overcome
n=5796
82.0%
§112 Overcome
n=3542

Specialization & Scale

H04W, H04L, G06F
Top CPC Subclasses
22%
Top-3 CPC Share
n=12386
13
Practitioners
n=12386
952.8
Apps / Practitioner
n=12386

Portfolio Summary

165
Total Pending OAs
106
Non-Final OAs
49
Final Rejections
10
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 42 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

21
Overdue
1
Due this week
12
Due this month
5
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 42 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (21)Due ≤ 7 days (1)Due ≤ 30 days (12)Due ≤ 60 days (5)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

69
Hard (42%)
67
Medium (41%)
26
Easy (16%)
3
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only2 (1%)
§101 + other12 (7%)
§103 only48 (29%)
§102 only6 (4%)
§112 only22 (13%)
Double-patenting only4 (2%)
Double-patenting + other13 (8%)
Multi-statute (no §101)55 (33%)
No statute on record3 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

100
Life Sciences
61% of docket
21
Information Tech
13% of docket
12
Communications
7% of docket
9
Semiconductors
5% of docket
21
Mechanical / Eng
13% of docket
2
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,650 h
Manual time on pending OAs
330 h
Time saved (low, 20%)
578 h
Time saved (mid, 35%)
14.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VINEIS, FRANK J 3 39.9% +44.8%
KAMARA, MOHAMED A 2 89.3% +8.6%
FRASER, STEWART A 2 86.0% +14.4%
NGUYEN, CHUONG M 2 72.8% +19.1%
GAUGER, PAUL RANDALL 2 59.3% +8.3%
HUYNH, PHUONG N 2 65.8% +53.6%
CHACKO DAVIS, DABORAH 2 72.0% +20.4%
HELLMAN, KRISTINA M 2 65.1% +55.5%
CORNET, JEAN P 1 41.9% +47.2%
MERRIAM, ANDREW E 1 28.3% +33.9%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18727567 USER EQUIPMENT AUTONOMOUS RESOURCE DETECTION FOR CALIBRATION KAMARA, MOHAMED A —
18727041 PHASE SHIFT MASK AND METHOD FOR MANUFACTURING PHASE SHIFT MASK FRASER, STEWART A —
18701343 WIRELESS POSITIONING KAMARA, MOHAMED A —
18277053 REFLECTIVE PHOTOMASK BLANK AND REFLECTIVE PHOTOMASK FRASER, STEWART A —

Hard Cases (69)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18728655 METHOD AND APPARATUS FOR SPLITTING DOWNLINK DATA IN A DUAL/MULTI CONNECTIVITY SYSTEM DONABED, NINOS 111d overdue
18027825 OPERATION METHOD AND OPERATION DEVICE FOR LIVING BODY BOWERS, NATHAN ANDREW 77d overdue
18744567 INFORMATION PROCESSING METHOD, PROGRAM, AND INFORMATION PROCESSING APPARATUS GUNN, JEREMY L 50d overdue
18985088 Apparatus Utilizing Smart Fabrics for Providing Protection of the Head and Brain from Injury in Six Degrees of Freedom NUNNERY, GRADY ALEXANDER 46d overdue
18033187 COMPOSITIONS AND METHODS FOR TREATING NEURONAL DISORDERS WITH CANNABINOIDS MOU, LIYUAN 45d overdue
18074369 METHOD OF MAPPING SPATIAL DISTRIBUTIONS OF CELLULAR COMPONENTS LU, FRANK WEI MIN 43d overdue
18409739 METHOD AND APPARATUS TO GENERATE AND AUGMENT DOCUMENT FORMS BLACKSTEN, SYDNEY LYNN 31d overdue
19112742 UNITARY REAR RAIL STRUCTURE FOR A VEHICLE AND METHODS O'NEILL, MATTHEW JAMES 9d overdue

Interview Candidates (15)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18558005 TRANSMISSION FOR TIME SYNCHRONIZATION NGUYEN, CHUONG M 35d overdue
18203348 IMMUNOMODULATOR ANTIBODY DRUG CONJUGATES AND USES THEREOF HELLMAN, KRISTINA M 26d overdue
17727395 ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE HUYNH, PHUONG N 2d overdue
17909730 CYCLIC PEPTIDES FROM THE C-TERMINUS OF ACETYLCHOLINESTERASE FOR TREATMENT OF SKIN DISORDERS AND FOR COSMETICAL USE HELLMAN, KRISTINA M 19d
19537121 N-PHENYL-3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS DUX4 INHIBITORS FOR THE TREATMENT OF E.G. NEUROMUSCULAR DISORDERS CORNET, JEAN P —
19531099 FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF MERRIAM, ANDREW E —
18727041 PHASE SHIFT MASK AND METHOD FOR MANUFACTURING PHASE SHIFT MASK FRASER, STEWART A —
18704362 CONTROLLING ACCESS FOR DEVICES WITH DIFFERENT CAPABILITIES NGUYEN, CHUONG M —

Client Portfolio (83 clients)

View all 83 →

Top Art Units

Art UnitApps
17376
16745
16544
16283
16533
26463
17453
16523
24123
16293

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19537121 N-PHENYL-3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS DUX4 INHIBITORS FOR THE TREATMENT OF E.G. NEUROMUSCULAR DISORDERS Altay Therapeutics, Inc. CORNET, JEAN P 1628 §102§103§112 Final Rejection — Pending Feb 11, 2026
19531099 FIBER BLEND COMPOSITIONS AND METHODS OF USE THEREOF Animal Microbiome Analytics, Inc. MERRIAM, ANDREW E 1791 §102§103§112 Final Rejection — Pending Feb 05, 2026
19366131 Products and Methods for Therapeutic Administration of Microorganisms to Non-Human Animals Animal Microbiome Analytics, Inc. BOWERS, ERIN M 1653 §103§112 Final Rejection — Pending Oct 22, 2025
19345449 DISPLAY DEVICE Nalux Co., Ltd. CATTANACH, COLIN J 2875 §102§103 Final Rejection — Pending Sep 30, 2025
19288840 CONFIGURED GRANTS FOR SIDELINK POSITIONING Nokia Technologies Oy LAFONTANT, GARY 2646 §102 Final Rejection — AI Ready Aug 01, 2025
19287566 COPING WITH CONSISTENT LISTEN-BEFORE-TALK FAILURE Nokia Technologies Oy HTUN, SAN A 2643 §103 Non-Final OA — AI Ready Jul 31, 2025
19231752 SECURE PLATFORM AND DATA REPOSITORY FOR FUR OR SKIN COMMODITIES We Plan For S.A. GARG, YOGESH C 3688 §101§112Other Non-Final OA — Pending Jun 09, 2025
19224364 HUMAN OR BOT ACTIVITY DETECTION Human Security, Inc. KEEHN, RICHARD G §102 Non-Final OA — Pending May 30, 2025
19222730 STING AGONIST IMMUNOSTIMULATORY ANTIBODY DRUG CONJUGATES Astellas Pharama Inc. CARTER, SANDRA DILLAHUNT 1674 §112 Non-Final OA — Pending May 29, 2025
19219645 ORTHODONTIC DEVICE Orthodontic Research And Development, S.L. MAI, HAO D 3772 §102§103 Non-Final OA — Pending May 27, 2025
19194738 CURRENCY MANAGEMENT SYSTEM AND ELECTRONIC SIGNATURE DEVICE Gve Ltd. BUI, TOAN D. 3693 §101§103 Non-Final OA — Pending Apr 30, 2025
19122881 LIQUID DELIVERY DEVICE Sumitomo Bakelite Co., Ltd. HERRMANN, JOSEPH S 3746 §103§112 Final Rejection — Pending Apr 21, 2025
19112742 UNITARY REAR RAIL STRUCTURE FOR A VEHICLE AND METHODS Autotech Engineering S.L. O'NEILL, MATTHEW JAMES 3614 §102§103 Final Rejection 9d overdue Pending Mar 18, 2025
19111180 UNMANNED AERIAL VEHICLES Linking Drones Ug KHALED, ABDALLA A 3667 §102§103§112 Non-Final OA — Pending Mar 12, 2025
19111128 VERTICAL TAKEOFF AND LANDING AERIAL VEHICLES Linking Drones Ug WALTER, KATHERINE JUNE 3647 §102§103§112 Non-Final OA — Pending Mar 12, 2025
19103776 WHOLE-CANE CO-FERMENTATION OF LIGNOCELLULOSE AND SOLUBLE SUGAR TO PRODUCE ETHANOL Terragia Biofuel Inc. MISHRA, DEEPA 1657 §102§103§112Other Non-Final OA — Pending Feb 13, 2025
19014842 PANEL WITH CONNECTOR Varidesk, LLC MAESTRI, PATRICK J 3635 §102§103§112 Non-Final OA — Pending Jan 09, 2025
19010569 METHOD OF MACHINING MOLD FOR MICROLENS ARRAY Nalux Co., Ltd. RAMOS, NICOLE N 3722 §112 Non-Final OA — Pending Jan 06, 2025
18985088 Apparatus Utilizing Smart Fabrics for Providing Protection of the Head and Brain from Injury in Six Degrees of Freedom Scarfe Technologies, Inc. NUNNERY, GRADY ALEXANDER 3732 §101§103§112 Non-Final OA 46d overdue Pending Dec 18, 2024
18875529 BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY Nikang Therapeutics, Inc. SHTERENGARTS, SAMANTHA L 1623 §112 Non-Final OA — Pending Dec 16, 2024
18871132 METHODS AND SYSTEMS FOR THREE-DIMENSIONAL PRINTING Prellis Biologics, Inc. AHMED ALI, MOHAMED K 1743 §103 Non-Final OA — Pending Dec 02, 2024
18868902 AXIAL INTERNAL COMBUSTION ENGINE Innengine, S.L. KIM, JAMES JAY 3747 §102§103§112 Non-Final OA — Pending Nov 25, 2024
18944944 PRESS FIT CONDULET DEVICES, ASSEMBLIES SYSTEMS AND METHODS FOR ELECTRICAL RACEWAY FABRICATION Eaton Intelligent Power Limited MCALLISTER, MICHAEL F 2847 §101§102§103 Non-Final OA — Pending Nov 12, 2024
18940077 THIN FILM TYPE FILTER FOR ATTENUATING LIGHT AND METHOD OF PRODUCING THE SAME Nalux Co., Ltd. AHVAZI, BIJAN 1763 §103§112 Non-Final OA — Pending Nov 07, 2024
18862043 CERAMIC MATRIX COMPOSITE AND METHOD FOR PRODUCING THE SAME Tosoh Corporation SCHLEIS, DANIEL J 1784 §102 Non-Final OA — Pending Oct 31, 2024
18861569 EMULSION BLEND FOR COATING CARBONATES Specialty Minerals (Michigan) Inc. HUANG, CHENG YUAN 1787 §103§112 Non-Final OA — Pending Oct 29, 2024
18859321 SEALING APPARATUS AND METHOD Automated Industrial Robotics Wakefield Limited SELLS, JAMES D 1745 §103 Non-Final OA — Pending Oct 23, 2024
18923249 OXYGEN GENERATING FACE MASKS Dermoq, Inc. LEE, SIN J 1615 §102§103DP Non-Final OA — Pending Oct 22, 2024
18915097 PRODUCTION OF ISOPRENOIDS Amyris, Inc. RAGHU, GANAPATHIRAM 1652 DP Non-Final OA — Pending Oct 14, 2024
18855291 METHOD FOR STYRENE MONOMER PRODUCTION Repsol, S.A VASISTH, VISHAL V 1771 §103 Non-Final OA — Pending Oct 08, 2024
18906619 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. ROBINSON, RENEE E 1772 §102§103 Non-Final OA — Pending Oct 04, 2024
18904545 OPTICAL SYSTEM PROVIDED WITH ATTENUATING AREA AND METHOD OF PRODUCING THE SAME Nalux Co., Ltd. WONG, TINA MEI SENG 2874 §103§112 Non-Final OA — Pending Oct 02, 2024
18898082 MYST Inhibitors Isosterix, Inc. HASTINGS, ALISON AZAR 1627 §102§112DP Non-Final OA — Pending Sep 26, 2024
18896091 COMMUNICATING WEIGHT SENSOR UNITS AND TECHNIQUES FOR USING SAME Inventor-E Limited SADATE-MOUALEU, MIREILLE SANDRA 2855 §103§112 Non-Final OA — Pending Sep 25, 2024
18848324 COMMUNICATION DEVICE, COMMUNICATION METHOD, COMMUNICATION PROGRAM, AND COMMUNICATION SYSTEM Kskb Co., Ltd. PHUNKULH, BOB A 2412 §103 Non-Final OA — Pending Sep 18, 2024
18843455 IMAGING DEVICE AND IMAGING METHOD Nikon Corporation SCHNASE, PAUL DANIEL 2877 §102§103§112 Non-Final OA 62d Pending Sep 03, 2024
18822053 LITHIUM STUFFED GARNET SETTER PLATES FOR SOLID ELECTROLYTE FABRICATION Quantumscape Battery, Inc. WIESE, NOAH S 1731 §102§103 Non-Final OA — Pending Aug 30, 2024
18821962 DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO Engene, Inc. BURKHART, MICHAEL D 1638 §101DP Non-Final OA — Pending Aug 30, 2024
18811626 IMAGE FORMING SYSTEM AND STORAGE MEDIUM Konica Minolta, Inc. DO, ANDREW V 2852 §102§103 Final Rejection 29d Pending Aug 21, 2024
18795968 METAL FOIL FOR SPRING MEMBER, SPRING MEMBER FOR ELECTRONIC DEVICE, PRODUCTION METHOD FOR METAL FOIL FOR SPRING MEMBER, AND PRODUCTION METHOD FOR SPRING MEMBER FOR ELECTRONIC DEVICE Toppan Holdings Inc. SCHWARTZ, CHRISTOPHER P 3616 §112DP Non-Final OA — Pending Aug 06, 2024
18835996 CALENDERED CATHODE COMPOSITIONS AND METHODS OF MAKING THEREOF Quantumscape Battery, Inc. HILTON, ALBERT MICHAEL 1723 §103 Non-Final OA — Pending Aug 05, 2024
18776978 RAPID CERAMIC PROCESSING TECHNIQUES AND EQUIPMENT Quantumscape Battery, Inc. WILSON, GREGORY A 3762 §102§112 Non-Final OA — Pending Jul 18, 2024
18776025 COMPOSITIONS AND METHODS FOR WOUND TREATMENT Eluciderm Inc. BERRIOS, JENNIFER A 1613 §112 Non-Final OA — Pending Jul 17, 2024
18728655 METHOD AND APPARATUS FOR SPLITTING DOWNLINK DATA IN A DUAL/MULTI CONNECTIVITY SYSTEM Nokia Solutions and Networks Oy DONABED, NINOS 2444 §101 Final Rejection 111d overdue AI Ready Jul 12, 2024
18727567 USER EQUIPMENT AUTONOMOUS RESOURCE DETECTION FOR CALIBRATION Nokia Technologies Oy KAMARA, MOHAMED A 2412 §103 Final Rejection — Pending Jul 09, 2024
18727674 DEVICE AND METHOD FOR REGULATING RELEASE OF ADENOSINE IN ORGANISM, AND USE Wenzhou Adopharm Technology Co., Ltd. WILSON, KAYLEE R 3700 §101§102§103§112 Non-Final OA — Pending Jul 09, 2024
18767515 PROCESS FOR PRODUCTION OF HYDRAULIC-CARBONATING BINDER SYSTEMS THROUGH MECHANOCHEMICAL ACTIVATION OF MINERALS Carbonbuilt, Inc. GREEN, ANTHONY J 1731 DP Non-Final OA — Pending Jul 09, 2024
18727041 PHASE SHIFT MASK AND METHOD FOR MANUFACTURING PHASE SHIFT MASK Tekscend Photomask Corp. FRASER, STEWART A 1724 §103Other Non-Final OA — Pending Jul 05, 2024
18758003 MECHANISM FOR CELL ACTIVATION Nokia Technologies Oy HOANG, THAI D 2463 §102§112 Non-Final OA — Pending Jun 28, 2024
18723184 SUPPRESSION OF NON-SPECIFIC SIGNALS BY EXONUCLEASES IN FISH EXPERIMENT California Institute Of Technology WOOLWINE, SAMUEL C 1681 §102§103§112 Non-Final OA — Pending Jun 21, 2024

View all 165 →

Managing Squire Pb (Sfr Office)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Squire Pb (Sfr Office)'s patent allowance rate?

83.1% of resolved applications prosecuted by Squire Pb (Sfr Office) were allowed, across 12,386 applications in USPTO records.

How many office actions does Squire Pb (Sfr Office) average before allowance?

3.78 office actions per allowed application on average.

How many pending office actions does Squire Pb (Sfr Office) have?

165 pending office actions as of October 2026, for 83 clients, before 156 examiners in 114 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month